DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Azulfidine (Sulfasalazine) - Interstitial Lung Disease - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Interstitial Lung Disease (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Azulfidine (Sulfasalazine) where reactions include interstitial lung disease. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Azulfidine side effects in

Reported by a pharmacist from Japan on 2012-04-04

Patient:

Reactions: Arthropathy, Interstitial Lung Disease, Infection

Drug(s) suspected as cause:
Azulfidine



Possible Azulfidine side effects in

Reported by a pharmacist from Japan on 2012-03-14

Patient:

Reactions: Arthropathy, Interstitial Lung Disease, Infection

Drug(s) suspected as cause:
Azulfidine



Possible Azulfidine side effects in

Reported by a pharmacist from Japan on 2012-03-09

Patient:

Reactions: Arthropathy, Interstitial Lung Disease, Infection

Drug(s) suspected as cause:
Azulfidine



Possible Azulfidine side effects in

Reported by a pharmacist from Japan on 2012-03-02

Patient:

Reactions: Interstitial Lung Disease

Drug(s) suspected as cause:
Azulfidine

Zyvox



Possible Azulfidine side effects in

Reported by a pharmacist from Japan on 2012-03-01

Patient:

Reactions: Interstitial Lung Disease

Drug(s) suspected as cause:
Azulfidine



Possible Azulfidine side effects in 70 year old male

Reported by a physician from Japan on 2011-11-23

Patient: 70 year old male, weighing 54.0 kg (118.8 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Azulfidine
    Dosage: 500 mg, 1x/day
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-04-14
    End date: 2009-05-22

Enbrel
    Dosage: 25 mg, weekly
    Indication: Rheumatoid Arthritis
    Start date: 2009-03-11
    End date: 2009-05-11

PEG-Intron
    Dosage: 80 ug, weekly
    Indication: Hepatitis C
    Start date: 2009-01-09
    End date: 2009-05-01

Rheumatrex
    Dosage: 2 mg, 2x/week
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-04-14
    End date: 2009-05-22

Other drugs received by patient: Folic Acid; Voltaren



Possible Azulfidine side effects in female

Reported by a physician from Japan on 2011-11-11

Patient: female, weighing 33.0 kg (72.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Azulfidine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Remicade
    Dosage: 3rd infusion
    Indication: Rheumatoid Arthritis
    Start date: 2007-06-29

Remicade
    Dosage: 2nd infusion
    Start date: 2007-06-01

Remicade
    Dosage: 1st infusion
    Start date: 2007-05-18

Rheumatrex
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 1999-03-01
    End date: 2007-07-08

Rimatil
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2000-08-02
    End date: 2007-07-08

Other drugs received by patient: Loxonin; Prednisolone; Prednisolone; Folic Acid; Gaslon N; Isoniazid; Alfarol; Prednisolone



Possible Azulfidine side effects in 72 year old male

Reported by a physician from Japan on 2011-11-03

Patient: 72 year old male, weighing 54.0 kg (118.8 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Azulfidine
    Dosage: 500 mg, 1x/day
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-04-14
    End date: 2009-05-22

Enbrel
    Dosage: 25 mg, weekly
    Indication: Rheumatoid Arthritis
    Start date: 2009-03-11
    End date: 2009-05-11

PEG-Intron
    Dosage: 80 ug, weekly
    Indication: Hepatitis C
    Start date: 2009-01-09
    End date: 2009-05-01

Rheumatrex
    Dosage: 2 mg, 2x/week
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-04-14
    End date: 2009-05-22

Other drugs received by patient: Diclofenac Sodium; Folic Acid



Possible Azulfidine side effects in

Reported by a physician from Japan on 2011-10-17

Patient:

Reactions: Interstitial Lung Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Azulfidine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017